Heart failure: an active role for GPs and patients
Early diagnosis of heart failure and effective management in primary care prolongs lives, keeps people out of hospital, and improves quality of life.
Start: 1 March 2021
The NPS MedicineWise program on heart failure has been developed in collaboration with the National Heart Foundation of Australia.
This activity has been approved for 2 points (CPD Activity) under the RACGP CPD Program for the 2020–2022 triennium (activity: 238049).
Small group meeting
This activity has been approved for 2 points (CPD Activity) under the RACGP CPD Program for the 2020–2022 triennium (activity: 237092).
This activity has been accredited for 1 hour under the educational activity category in the ACRRM PD Program for the 2020–2022 triennium (activity: 22014).
Small group meeting
This activity has been accredited for 1 hour under the educational activity category in the ACRRM PD Program for the 2020–2022 triennium (activity: 21984).
Managing heart failure is complex. High rates of mortality and hospital readmission make this a challenging condition for patients and their GPs. But there are clear principles to support effective management in primary care.
This educational visit is part of a multifaceted program designed to:
- support GPs in the early diagnosis and classification of heart failure
- provide clinical guidance on initiation and ongoing management of medicines
- empower patients with effective self-management strategies to improve their quality of life.
Educational visits are available as:
- One-on-one: a 30-minute in-practice discussion for GPs, tailored to individual learning needs.
- Small group: a 1-hour group discussion for GPs, pharmacists and nurses.
- Virtual visits: via video call. Available to support practices who wish to continue educational activities without a face-to-face appointment.
All visits will comply with current state and territory regulations for social distancing.
Learning outcomes for educational visits:
Assess people with suspected heart failure and refer for echocardiogram when required to help confirm diagnosis and guide management.
Apply Australian guideline recommendations to up-titrate heart failure medicines to target or maximum tolerated doses for people with heart failure reduced ejection fraction (HFrEF) to reduce hospitalisations and save lives.
Create a management plan with patients which includes non-pharmacological and pharmacological treatments for heart failure and any co-morbidities, to improve patient outcomes.
Review and deprescribe, where possible, potentially harmful medicines to reduce cardiac risk and exacerbation of heart failure.
Evaluate patients with heart failure who would benefit from referral to support/specialist services to improve medicines up-titration and adherence, and reduce rehospitalisations.